Advanced Medical Solutions Group PLC Fundamentals Datasheet and Stock Analysis


Advanced Medical Solutions Group PLC Company Logo
Advanced Medical Solutions Group plc is engaged in the design, development, manufacture and distribution of materials for use in advanced woundcare products and surgical dressings, as well as medical adhesives and sutures for closing and sealing tissue. It operates through four segments: Branded Direct, Branded Distributed, OEM (Original Equipment Manufacturer) and Bulk Materials. Its Branded Direct segment is engaged in selling, marketing and innovation of its branded products sold directly by its sales teams. Its Branded Distributed segment is engaged in distribution, marketing and innovation of its brands sold by distributors in markets not serviced by its sales team. Its OEM segment is engaged in selling, marketing and innovation of its products supplied to partners under their brands. Its Bulk Materials segment is engaged in selling, marketing and innovation of bulk materials to medical device partners and convertors. Its products include ActivHeal, LiquiBand and RESORBA.

  • Current Price:
  • Industry:
     Health Care
  • Sector:
     Health Care
  • ISIN:
  • Market Sector:
  • Main Indices:
  • Country of register:
     Great Britain
  • Currency:
  • Shares in Issue:
  • Market Cap:
  • Date Listed:
Operation Breakdown
Geographical - by origin (turnover)
Product (turnover)


Activity Data Not Available

Company Information

CEO: A Christopher (Chris) Meredith  CFO: Eddie Johnson  Non-Executive Director: Stephen Gerard Bellamy Grahame Cook  Non-Executive Chairman: Peter Allen  Senior Independent Non-Executive Director: Penelope Anne Freer  

  • Registrars:
     Capita Registrars
  • Address:
     Premier Park, 33 Road One WInsford Industrial Estate Winsford, Cheshire
  • Phone:
     +44 (0) 1606 863500
  • Website:
Composite Ranking: 47
Historic EPS Ranking: 7
Forecast EPS Ranking: 
Price Relative Strength: 16
Industry Strength: C
SMR Ranking: C
ROCE Ranking: D
Accumulation/Dist: C
Mkt Accumulation/Dist: C
Unbroken Annual EPS: D
Unbroken Interim EPS: D
PEG Current Ranking: A
PEG Forecast Ranking: B
PE Current Ranking: H
PE Forecast Ranking: F
Margin Current Ranking: C
Margin Forecast Ranking: B
Add Indicator


Takes the average of data over a period of time, and migrates the period across the data series one data point at a time. This formula smooths a data series and makes analysing volatile data easier.
Operating Profit/(loss)£m13.7315.1717.0419.1125.2428.4724.2410.73£m0.00
Profit Before Tax£m13.1415.2217.0019.1025.2828.2724.2610.09£m26.16
Profit After Tax£m11.3712.8614.1215.6920.1322.4918.928.58£m0.00
Profit After Tax (from discontinued operations)£m0.£m0.00
Overall Profit for the Period£m11.3712.8614.1215.6920.1322.4918.928.58£m0.00
EPS Growth%14.7411.569.8710.4827.2410.86(16.23)(54.82)%92.00
Earnings Per Sharep5.456.086.687.389.3910.418.723.94p9.45
Op. Cash Flow P/Sp6.747.8410.089.337.9210.0310.010.00£0.00
Cash Flow P/S Grth%1,504.7616.3228.57(7.44)(15.11)26.64(0.20)(100.00)%0.00
Net Cash Flow P/Sp0.£0.00
Capital Exp P/S££0.00
Tax Rate%
P/E Ratiox19.6020.1027.1029.6033.4025.3032.9060.70x24.30
P/E Growth££0.30
Turnover Per Share££0.00
Pre-Tax Profit / Share££0.00
Operating Margin%23.0724.0824.8422.9626.0427.7523.6812.36%0.00
Mkt Cap£m231.09267.81395.39477.81684.67575.31624.87521.45£m0.00
Dividend Per Sharep0.600.700.800.921.101.321.551.70p1.88
DPS Growth%
Dividend Yield%0.600.600.400.400.300.500.500.70%0.80
Dividend Coverx9.539.138.698.438.718.146.002.58x0.00
Shareholder Funds£m86.0993.05103.66125.53152.44172.73191.24202.21£m0.00
Net Borrowings£m(5.26)(17.28)(34.20)(51.12)(62.45)(76.39)(64.75)(53.83)£m0.00
Net Assets£m86.0993.05103.66125.53152.44172.73191.24202.21£m0.00
Net Assets P/S££0.00
Latest Forecast
Div Yield0.7%0.8%
Div Cover2.6%4.8%
Op Margin12.4%22.6%
Director Deals
Traded Action Notifier Price Amount Value
25-Mar-21BuyA Christopher (Chris) Meredith236.53p33,390,378,977.37
25-Mar-21SellA Christopher (Chris) Meredith236.50p33,390,378,967.35
25-Mar-21BuyA Christopher (Chris) Meredith236.53p7,900,318,685.87
25-Mar-21SellA Christopher (Chris) Meredith236.50p7,900,318,683.50
08-Apr-20BuyPenelope Anne Freer247.00p2,112,635,216.64
06-Apr-20BuyA Christopher (Chris) Meredith235.00p8,500,319,975
06-Apr-20BuyA Christopher (Chris) Meredith235.00p4,500,310,575
03-Apr-20SellA Christopher (Chris) Meredith235.00p4,500,310,575
01-Apr-20SellA Christopher (Chris) Meredith258.03p19,993,351,587.14
01-Apr-20SellEddie Johnson258.03p15,952,341,160.31
First PagePrev PageNext Page  Rows per page
215m    Major: 35%    Director: 1%
Notifier Holding Value
A Christopher (Chris) Meredith1,486,911,769,319.38
Stephen Gerard Bellamy100,000ý,500
Eddie Johnson67,967¬,296.34
Peter Allen50,000~,750
Penelope Anne Freer16,000(,560
  Rows per page
Gearing & Cover
News Title Date Time Source
Total Voting Rights29-May-2014:17RNS
Annual Report, AGM and Board Change18-May-2007:00RNS
Director/PDMR Shareholding12-May-2018:16RNS
Director/PDMR Shareholding11-May-2016:01RNS
Total Voting Rights30-Apr-2014:00RNS
Director/PDMR Shareholding17-Apr-2016:30RNS
PCA Dealing14-Apr-2007:00RNS
Director/PDMR and PCA Shareholding06-Apr-2009:26RNS
Clinical Development Programme06-Apr-2007:01RNS
Director/PDMR Shareholding06-Apr-2007:00RNS
First PagePrev PageNext Page  Rows per page
Broker Opinion
Date Broker Name Rec Price Old Price Target New Price Target Broker Change
04-Mar-15Panmure GordonHold143.50p102.00p126.00pReiteration
04-Mar-15Numis SecuritiesHold143.00p122.00p137.00pReiteration
04-Mar-15N 1 SingerHold143.00p0.00p0.00pReiteration
04-Mar-15Investec SecuritiesBuy143.25p0.00p152.00pReiteration
04-Mar-15Canaccord GenuitySell144.75p0.00p112.00pReiteration
25-Jun-13Nplus1 BrewinHold72.50p77.00p77.00pReiteration
29-Aug-12Singer Capital MarketsBuy70.00p80.00p82.00pUpgrade
26-Jun-12Peel Hunt LimitedBuy66.00p85.00p0.00pUpgrade
First PagePrev PageNext Page  Rows per page

This functionality requires you to login

Click here to login
Or register for a new account